Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1019875

registered interest
date	04/12/2018
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Schools: South Gloucestershire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, how much funding his Department has allocated through the National Funding Formula to schools in South Gloucestershire in (a) 2017-18, (b) 2018-19 and (c)2019-20.
tabling member constituency	Thornbury and Yate
tabling member printed	Luke Hall
uin	198885
answer	answer is ministerial correction date of answer 12/12/2018 answer text <p>The table below sets out the funding allocated to South Gloucestershire to fund schools in the years requested. It also sets out the high needs funding given to the local authority, which is for pupils with complex special educational needs and disabilities. Some of this funding goes to mainstream schools to help them meet the needs of these pupils.</p><table><tbody><tr><td><p><strong>Year</strong></p></td><td><p><strong>Schools block allocation </strong></p></td><td><p><strong>High needs allocation</strong></p></td></tr><tr><td><p>2017-18[1]</p></td><td><p>£151.15 million</p></td><td><p>£29.66 million</p></td></tr><tr><td><p>2018-19[1]</p></td><td><p>£151.19 million</p></td><td><p>£31.04 million</p></td></tr><tr><td><p>2019-20 (illustrative)[2]</p></td><td><p>£154.76 million</p></td><td><p>£31.33 million</p></td></tr></tbody></table><p>In addition to the funding allocated through the national funding formula, schools will receive funding from specific grants - for example, through the pupil premium, or the PE and sports premium.</p><p>Local authorities remain responsible for setting school budgets at a local level, and individual schools may see their funding change due to changing pupil numbers or characteristics, or changes in how the local authority distributes funding.</p><p> </p><p>[1] Figures are from the Schools Block of the Dedicated Schools Grant (DSG) for 2017-18 and 2018-19. In addition, the national funding formula (NFF) came into force in April 2018 for the 2018-19 financial year, so South Gloucestershire’s 2017-18 allocation was not calculated using the national funding formula.</p><p>[2] Figures are from the NFF allocations published in July 2018 for 2019-20. DSG figures for 2019-20 as these are not yet published. 2019-20 NFF figures are illustrative because they will be updated to reflect the latest pupil numbers when the 2019-20 DSG allocations are confirmed.</p><p> </p> answering member constituency Bognor Regis and Littlehampton answering member printed Nick Gibb question first answered 12/12/2018 16:35:52 answering member 111 label Biography information for Nick Gibb
tabling member	4450 label Biography information for Luke Hall

1015223

registered interest
date	26/11/2018
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Horses: Animal Welfare
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, what recent assessment he has made of the potential merits of bringing forward legislative proposals on the tethering of horses.
tabling member constituency	Thornbury and Yate
tabling member printed	Luke Hall
uin	195690
answer	answer is ministerial correction date of answer 04/12/2018 answer text <p>Under the Animal Welfare Act 2006 (the 2006 Act), it is an offence to fail to provide for an animal’s welfare or to cause it any unnecessary suffering. The 2006 Act is backed up by the statutory Code of Practice for the Welfare of Horses, Ponies, Donkeys and Their Hybrids (the Code). The Code provides owners and keepers with information on how to meet the welfare needs of their horses and includes a specific section on how to tether a horse. Local authorities have powers under the 2006 Act to investigate allegations of cruelty or poor welfare. In addition, welfare organisations such as the RPSCA and World Horse Welfare (WHW) may also investigate such matters. If anyone is concerned about the way a horse has been tethered, they should report the matter either to the relevant local authority, or to the RSPCA or WHW who can investigate. If a horse is found not to be tethered appropriately, it could lead to a prosecution under the Animal Welfare Act 2006. I therefore consider that there is legislation and guidance in place in respect of tethering of horses.</p> answering member constituency Macclesfield answering member printed David Rutley question first answered 04/12/2018 11:40:00 answering member 4033 label Biography information for David Rutley
tabling member	4450 label Biography information for Luke Hall

1015225

registered interest
date	26/11/2018
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Animal Welfare
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, what information his Department holds on how many local authorities have not appointed animal welfare inspectors with training to enforce the Animal Welfare Act 2006 with respect to equine welfare.
tabling member constituency	Thornbury and Yate
tabling member printed	Luke Hall
uin	195692
answer	answer is ministerial correction date of answer 04/12/2018 answer text <p>Defra does not hold records of how many local authorities have not appointed or trained inspectors to enforce equine welfare issues.</p><p> </p><p>Local authorities are required to enforce <em>The Animal Welfare (Licensing of Activities Involving Animals) (England) Regulations 2018 </em>which includes the licensing of businesses that hire out horses for riding or instruction in riding and which requires inspectors to be suitably qualified. We would expect most local authorities, therefore, to have inspectors trained in enforcing equine welfare more generally.</p> answering member constituency Macclesfield answering member printed David Rutley question first answered 04/12/2018 17:05:54 answering member 4033 label Biography information for David Rutley
tabling member	4450 label Biography information for Luke Hall

1015226

registered interest
date	26/11/2018
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Animal Welfare
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, what steps his Department are taking are to encourage local authorities to appoint animal welfare inspectors.
tabling member constituency	Thornbury and Yate
tabling member printed	Luke Hall
uin	195693
answer	answer is ministerial correction date of answer 04/12/2018 answer text <p>Defra does not hold records of how many local authorities have not appointed or trained inspectors to enforce equine welfare issues.</p><p> </p><p>Local authorities are required to enforce <em>The Animal Welfare (Licensing of Activities Involving Animals) (England) Regulations 2018 </em>which includes the licensing of businesses that hire out horses for riding or instruction in riding and which requires inspectors to be suitably qualified. We would expect most local authorities, therefore, to have inspectors trained in enforcing equine welfare more generally.</p> answering member constituency Macclesfield answering member printed David Rutley question first answered 04/12/2018 17:09:02 answering member 4033 label Biography information for David Rutley
tabling member	4450 label Biography information for Luke Hall

969030

registered interest
date	06/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps the Government has taken to ensure that (a) negotiations between Vertex Pharmaceuticals and NHS England on access to Orkambi for people with cystic fibrosis proceed without further delay and (b) an agreement is reached between the two parties.
tabling member constituency	Thornbury and Yate
tabling member printed	Luke Hall
uin	171383
answer	answer is ministerial correction date of answer 14/09/2018 answer text <p>It is crucial that patients have access to the most effective and innovative medicines at a price that represents value to the National Health Service. While Ministers are keeping a very close eye on negotiations, it is the responsibility of NHS England as the commissioner and the National Institute for Health and Care Excellence (NICE) as the independent body that is responsible for making recommendations on whether drugs and other treatments represent a clinically and cost-effective use of NHS resources, to work with Vertex to agree a deal to secure the best outcome for patients and a price for Orkambi that is fair and responsible.</p><p> </p><p>NHS England has proposed its best offer ever for a drug. This offer, in the region of £500 million over five years, is the largest ever commitment of its kind in the 70-year history of the NHS. This would guarantee immediate and expanded access to both Orkambi and the drug Kalydeco for patients who need it. Whilst it is disappointing that Vertex has not taken up NHS England’s offer, we are pleased to hear that it has responded positively to NHS England’s and NICE’s latest offer to meet. The Parliamentary Under-Secretary of State for Health (Lord O’Shaughnessy), the Secretary of State for Health (Rt. hon. Matt Hancock MP) and I have and continue to urge Vertex to reconsider this fair offer.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 171384 question first answered 14/09/2018 13:32:27 answering member 4067 label Biography information for Steve Brine
tabling member	4450 label Biography information for Luke Hall

969031

registered interest
date	06/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the oral contribution of the Parliamentary Under-Secretary of State for Health and Social Care of 17 July 2018, Official Report, column 384, what progress the Government has made on access to Orkambi in England since Vertex Pharmaceuticals was called on to accept NHS England’s proposal to make that drug available to people with cystic fibrosis.
tabling member constituency	Thornbury and Yate
tabling member printed	Luke Hall
uin	171384
answer	answer is ministerial correction date of answer 14/09/2018 answer text <p>It is crucial that patients have access to the most effective and innovative medicines at a price that represents value to the National Health Service. While Ministers are keeping a very close eye on negotiations, it is the responsibility of NHS England as the commissioner and the National Institute for Health and Care Excellence (NICE) as the independent body that is responsible for making recommendations on whether drugs and other treatments represent a clinically and cost-effective use of NHS resources, to work with Vertex to agree a deal to secure the best outcome for patients and a price for Orkambi that is fair and responsible.</p><p> </p><p>NHS England has proposed its best offer ever for a drug. This offer, in the region of £500 million over five years, is the largest ever commitment of its kind in the 70-year history of the NHS. This would guarantee immediate and expanded access to both Orkambi and the drug Kalydeco for patients who need it. Whilst it is disappointing that Vertex has not taken up NHS England’s offer, we are pleased to hear that it has responded positively to NHS England’s and NICE’s latest offer to meet. The Parliamentary Under-Secretary of State for Health (Lord O’Shaughnessy), the Secretary of State for Health (Rt. hon. Matt Hancock MP) and I have and continue to urge Vertex to reconsider this fair offer.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 171383 question first answered 14/09/2018 13:32:27 answering member 4067 label Biography information for Steve Brine
tabling member	4450 label Biography information for Luke Hall

942538

registered interest
date	16/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care what plans he has to ensure his Department continues to engage and meet with NHS England and Vertex to discuss access to Orkambi.
tabling member constituency	Thornbury and Yate
tabling member printed	Luke Hall
uin	164468
answer	answer is ministerial correction date of answer 20/07/2018 answer text <p>NHS England has been in intensive discussions with Vertex to encourage it to price Orkambi at a level that would allow NHS England to fund its use without adversely impacting other patients. I and the Parliamentary Under-Secretary of State for Health (Lord O’Shaughnessy) have been keeping an extremely close eye on these discussions and wrote to Vertex in April, urging it to commit to pricing that is responsible and proportionate. I also re-iterated this message in the adjournment debate on 17 July, Official report, columns 383-4.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/07/2018 10:09:26 answering member 4067 label Biography information for Steve Brine
tabling member	4450 label Biography information for Luke Hall

942539

registered interest
date	16/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether ensuring access to Orkambi for people with cystic fibrosis is a priority for his Department.
tabling member constituency	Thornbury and Yate
tabling member printed	Luke Hall
uin	164469
answer	answer is ministerial correction date of answer 20/07/2018 answer text <p>It is a key commitment of this Government to ensure that people with comparatively rarer conditions, like cystic fibrosis, get the same quality, safety and efficacy in medicines as those who have more common conditions.</p><p> </p><p>However, it is also necessary that Vertex prices Orkambi fairly and responsibly. That is why we must go through the right process with Vertex and NHS England, not the Government, working together to secure the best outcome for patients. NHS England has been in intensive discussions with Vertex to encourage it to price Orkambi at a level that would allow NHS England to fund its use without adversely impacting other patients. I and the Parliamentary Under-Secretary of State for Health (Lord O’Shaughnessy) have been keeping an extremely close eye on these discussions and wrote to Vertex in April, urging it to commit to pricing that is responsible and proportionate. I also re-iterated this message in the adjournment debate on 17 July, Official report, columns 383-4.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/07/2018 10:10:54 answering member 4067 label Biography information for Steve Brine
tabling member	4450 label Biography information for Luke Hall

942540

registered interest
date	16/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether a date has been set for the next meeting between NHS England and Vertex to discuss access to the drug Orkambi.
tabling member constituency	Thornbury and Yate
tabling member printed	Luke Hall
uin	164470
answer	answer is ministerial correction date of answer 20/07/2018 answer text <p>We are informed by NHS England that at the last meeting on 4 July, it was agreed that both parties would take time to reflect before a further meeting was arranged. NHS England has subsequently made a substantially increased proposal to Vertex and has offered to meet to discuss and clarify any aspects as required by the company.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/07/2018 09:48:08 answering member 4067 label Biography information for Steve Brine
tabling member	4450 label Biography information for Luke Hall

942541

registered interest
date	16/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his Department's policy is on Vertex (a) waiving its confidentiality clause on the negotiations around NHS access to the drug Orkambi and (b) disclosing details of its offer to NHS England.
tabling member constituency	Thornbury and Yate
tabling member printed	Luke Hall
uin	164471
answer	answer is ministerial correction date of answer 20/07/2018 answer text <p>It is not in the Department’s gift to impose any requirement upon Vertex to waive its confidentiality clause or to disclose details of any offer in the negotiations around National Health Service access to the drug Orkambi. However, Ministers at the department have publicly urged Vertex to consider the offer made by NHS England and to waive confidentiality so that we can all see, in the interests of transparency, the kind of prices it is seeking to charge the NHS.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/07/2018 09:43:39 answering member 4067 label Biography information for Steve Brine
tabling member	4450 label Biography information for Luke Hall